Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agatroban versus tirofiban for progressive stroke
ChiCTR2100049825Phase 4Not yet recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of argatroban, tirofiban, aspirin and clopidogrel in ischemic stroke and stroke (3 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoints: NIHSS, mRS and 3 more. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
argatrobantirofibanaspirinclopidogrel
03
Conditions
ischemic strokestroke
Beyond the preview
Go deeper on ChiCTR2100049825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049825.